Medine.co.uk

Gaviscon Advance Mint Chewable Tablets

Document: label-leaflet MAH BRAND_PL 00063-0613 change

Reckitt Benckiser 0002-pl00063-0613-spc-variation

Gaviscon Advance Mint Chewable


60


CHEWABLE TABLETS


KEEP OUT OF THE REACH AND SIGHT OF CHILDREN. See leaflet for further information.


Gaviscon

ADVANCE MINT CHEWABLE TABLETS Sodium alginate Potassium bicarbonate


Manufacturer and Product Licence Holder in UK: Reckitt Benckiser Healthcare (UK) Limited, Dansom Lane, Hull, HU8 7DS. UK.

UK Distributors: Forum Health Products Ltd.


Peel here. Do not remove.




Gaviscon and (J) are trade marie. PL 00063^0613.


;BAVISC0rc ADVflMCFMIlMT CHEWABLETABLETS

I Sodium alginate and potassium bicarbonate

[PATIENT INFORMATION LEAFLET

'PLEASE READ THIS LEAFLET CAREFULLY BEFORE

VOU TAKE THIS MEDICINE. IF YOU ARE NOT SURE

ABOUT ANYTHING ASK YOUR PHARMACIST OR

[DOCTOR.

1. What is this medicine and what is it used for?

gaviscon Advance Mint Chewable Tablets belong to a group of medicines called 'reflux suppressants', which form a protective layer on top of the stomach contents to prevent stomach acid escaping from the stomach where it works into the food pipe causing pain and discomfort.

Gaviscon Advance MihfChewa'breTablets are used-for the treatment of symptoms of gastro-oesophageal reflux such as acid regurgitation, heartburn and indigestion, which may occur, for example, following meals or during pregnancy, and in patients with symptoms related to oesophagitis. It can be used to relieve the symptoms of conditions such as hiatus hernia (protrusion of muscle through a muscle wall), symptoms of hoarseness and other voice disorders, sore throat and cough associated with reflux. It can be taken to control heartburn symptoms which may occur while taking, or following withdrawal of medication to reduce stomach acid such as Proton Pump Inhibitor (PPI's) or H2 Antagonists.    RR.


Peel

Here


2. TTefore taking Gaviscon Advance Mint Chewable

Tablets

Do not take Gaviscon Advance Mint Chewable Tablets if you

•    are allergic to any of the ingredients listed in Section 6

•    have a condition called phenylketonuria (as this product is sweetened with aspartame, a source of phenylalanine which is harmful to patients with phenylketonuria).

Please consult your doctor before taking Gaviscon

Advance Mint Chewable Tablets if you

•    are on a potassium, sodium or calcium restricted diet, as each two tablet dose contains small amounts of sodium (4.6mmol), potassium (2.0mmol) and calcium (2.0mmol)

suffer from heart disease or kidney disease


• are taking diuretics fwater tablets'I For high blooc pressure as the salt content of these tablets car affect the above diseases and the effect of diuretics Pregnancy and breastfeeding You can take this product if you are pregnant or breastfeeding.

3. How to take Gaviscon Advance Mint Chewable Tablets

For oral use only.

Adults including the elderly and children 12 years and over

Take 1-2tablets after meals and at bedtime, or as directerj Chew thoroughly before swallowing.    i

___________________________PB48680!



Children under 12 years

and include rash, difficulty breathing, dizziness due to

Should only be taken on medical advice.

an allergic reaction to the ingredients.

After taking this product

If you experience these or any other effects not listed,

|* If you forget a dose, do not double the dose next time,

stop taking the tablets and consult your doctor

CD

CD

i just skip it and carry on as before.

immediately.

• If you take too much, you may feel bloated. It is unlikely

If you get any side effects, talk to your doctor, pharmacist

LL.

to cause you harm, but please consult your doctor or

or nurse. This includes any possible side effects not listed

+-»

pharmacist.

in this leaflet. You can also report side effects directly via

C

f As with all medicines, treatment should be as short as

the Yellow Card Scheme at:

i possible.

"http://www.mhra.gov.uk/yellowcard". By reporting side

LI—

• If symptoms persist for longer than 7 days, consult

effects, you can help provide more information on the

your doctor.

safety of this medicine.

4. Possible side effects

Side effects are very rarejless than 1 in 10,000 usersj

RB48681

,





jEAVISCOM ADVAINfCElMINTCHEWABLETABLETS

i Sodium alginate and potassium bicarbonate

iPATIENT INFORMATION LEAFLET

'PLEASE READ THIS LEAFLET CAREFULLY BEFORE

YOU TAKE THIS MEDICINE. IF YOU ARE NOT SURE

ABOUT ANYTHING ASK YOUR PHARMACIST OR

DOCTOR.

1. What is this medicine and what is it used for?

jGaviscon Advance Mint Chewable Tablets belong to a group of medicines called'reflux suppressants', which jform a protective layer on top of the stomach contents to prevent stomach acid escaping from the stomach where it works into the food pipe causing pain and discomfort.


GavTscon Advance MinfChewableTablets are usetffor the treatment of symptoms of gastro-oesophageal reflux such as acid regurgitation, heartburn and indigestion, which may occur, for example, following meals or during pregnancy, and in patients with symptoms related to oesophagitis. It can be used to relieve the symptoms of conditions such as hiatus hernia (protrusion of muscle through a muscle wall), symptoms of hoarseness and other voice disorders, sore throat and cough associated with reflux. It can be taken to control heartburn symptoms which may occur while taking, or following withdrawal of medication to reduce stomach acid such as Proton Pump Inhibitor (PPI's) or H2 Antagonists.    RR


PRINTING READS This Way


Peel

Here


1. TTefore talcing Gaviscon Advance Mint Chewable Tablets

Do not take Gaviscon Advance Mint Chewable Tablets if you

•    are allergic to any of the ingredients listed in Section 6

•    have a condition called phenylketonuria (as this product is sweetened with aspartame, a source of phenylalanine which is harmful to patients with phenylketonuria).

Please consult your doctor before taking Gaviscon Advance Mint Chewable Tablets if you

•    are on a potassium, sodium or calcium restricted diet, as each two tablet dose contains small amounts of sodium (4.6mmol), potassium (2.0mmol) and calcium (2.0mmol)

• suffer from heart disease or kidney disease


• are taking diuretics (water tablets'!Tor high blood pressure as the salt content of these tablets can affect the above diseases and the effect of diuretics, Pregnancy and breastfeeding You can take this product if you are pregnant or breastfeeding.

3. How to take Gaviscon Advance Mint Chewable Tablets

For oral use only.

Adults including the elderly and children 12 years and over

Take 1-2tablets after meals and at bedtime, or as directec Chew thoroughly before swallowing.

__________________________-RB4868C




(Children under 12 years

(Should only be taken on medical advice.

After taking this product

(• If you forget a dose, do not double the dose next time, ' just skip it and carry on as before, j* If you take too much, you may feel bloated. It is unlikely ( to cause you harm, but please consult your doctor or i pharmacist.

(• As with all medicines, treatment should be as short as i possible.

(• If symptoms persist for longer than 7 days, consult 1 your doctor.

(4. Possible side effects

Sid.e_effe.cls_arevery rarejlesslhan 1_in lOJDQOusers) _ _


and include rash, difficulty breathing, dizziness due to an allergic reaction to the ingredients.

If you experience these or any other effects not listed, stop taking the tablets and consult your doctor immediately.

If you get any side effects, talkto your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet You can also report side effects directly via the Yellow Card Scheme at

"http://www.mhra.gov.uk/yellowcard". By reporting side effects, you can help provide more information on the safety of this medicine.

____________________________RB4BB81



5.    "How to store Gaviscon Advance Mint GRewable Tablets

KEEP OUT OFTHE REACH AND SIGHT OF CHILDREN. Store in the orginal package. Do not store above 30°C. Do not use after the expiry date shown after 'EXP' on the pack.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist howto dispose of medicines no longer required. These measures will help to protect the environment.

6.    Further information

Each tablet contains 500mg sodium alginate and lOOmg potassium bicarbonate.as the active ingredients. The other .ingredients are mannitol (_E42J), cajcjum


carbonate, macrogol 20j(M, copovidone, magnesium! stearate, aspartame (951), acesulfame potassium andi mint flavour.    (

Manufacturer and Product License Holder: ReckittJ Benckiser Healthcare (UK) Ltd, Damson Lane, Hull UK; HU87DS.    (

Gaviscon and ® are trademarks.

Leaflet last revised May 2014.    1




• •

• •

• •

• •

• •

• •

• •

• •

• ••

• •

• •

• •

• •

• •

• •

• •

• •


1.3.2 Mock-up

Gaviscon Advance Chewable National Tablets 0019964


Page 2


WIDTH = 223 mm


$>. ©..    ^    ©1^7


JS>5T©

afi!


of*


A4fS&>^r .rd\    ~ "5r^


*• >

.pK


RBH Artwork arid Print Specification


Trident Reference No: Action / Version: Brand:

Brand Platform:

Sub Platform:

Sub Brand:

Format:

Delivery:

Pack Size:

Country:

Date Created:

Date Modified:


TR429435

B

Gaviscon

Adult

500mg Tablet

Peppermint

Tablet

Blister

na

UK

02/11/10

04/11/10


O

cn

CN

o

co

CM


o

CD


O

LO

CN


H Contact:


Lori Glasgow


Artwork Type: Commercial Print

Component Code (zd if applicable):

Parent Technical Packaging Specification:


0311811

D0000636


CAD Cam Ref: G-foil-D0000636~223mm Printer:    Constantia Printers

Substrate:    Aluminium Foil


O

CN


O

- m CN

O

CN

CN


Pharmacode Reads This Way


Edgemark Position:    Na

Pharmacode No/NE: 11000110(453)


O

O

CN


^ tasfft) a'>j0&z*&k


Or*'*

**5*7^    a/ftizh^^

afi W    ^p*V*^ /sA^ffe


©


^ ©. «*.

A)    fiA


aV'55S^^^ ® ©#©x 0A    (jNi


^ -x*t


,«a*8'

CV“'

?v


-'00 ^


©


. • (JS6


vA-'

*'!« esOoA


©


0/*


-Hi, W i&P* srs <>iS^


O

cn


Print and Technical Colours


COLOURS TO MATCH RECOGNISED STANDARDS


BARCODE INFO


o

co


O

c**.


O

LD


O

ln


o

N"


O

- on


o

CN


■^ifl


>*■    © J5© <*aV!



iv^zTV


.«S»V


:C>!


!S> ^ 'S'V*


V


t


TDD1022/16


CUSTOMER 1MF0: Minimum Point Size = 5.5 pt


CUSTOMER 1ME0:

Cutter extended to show more repeat


Barcode Type:    Not    Known

Barcode Number:    N/A

Magnification:    N/A

BWR:    N/A

Truncated by (smallest Bar): N/A Encoded Data:_N/A_


All other aspects of the bar code to conform to the current GS1 Operating Manual or other agreed commercial standard.


[£*

TRIDENT


Connaught House, Connaught Road, Kingswood Business Park, Hull, HU7 3A?, England. T: +44 (0) 1482 828100


Please note that any low resolution paper Canon colour copies associated with this job should be referred to for content, layout and colour separation only.


STUDIO USE ONLY Lee Hardey    vi

Sm»Art check results: G=1;0=0;R=0; -LH-04/11/1008:1151


ARTWORK APPROVAL


Approved by Sonoco Trident on behalf of Reckitt Benckiser

Signed:______________________

Date:_______________________


UNDER NO CIRCUMSTANCES SHOULD THIS ARTWORK BE ALTERED WITHOUT PRIOR PERMISSION FROM TRIDENT.

Tel. Alan Smith: +44 (0)1482 710304


o

o


o

cn


o

co


o

C*N


o

CD


o

LO


o


O

CN


O CHEWABLE I £ TABLETS


GAVISCON

ADVANCE MINT CHEWABLE TABLETS


O CHEWABLE I £ TABLETS


GAVISCON


%


f ADVANCE

MINT CHEWABLE TABLETS

sodium alginate potassium bicarbonate

Heartburn and Indigestion > Long Lasting >


GAVI SCON


ADVANCE



f ^ TABLETS


MINT CHEWABLE TABLETS


RBH Artwork

and Print Specification

Trident Reference No: TR377640

Action / Version:

C

Brand:

Gaviscon

Brand Platform:

Adult

Sub Platform:

500mg Tablet

Sub Brand:

Peppermint

Format:

Tablet

Delivery:

Blister

Pack Size:

12s

Country:

UK

Date Created:

25/05/10

Date Modified:

14/10/10

RBH Contact:

Lori Glasgow

Artwork Type: Commercial Print

Component Code (2D if applicable):    0284409


SPap^J,ioni:CalPaCka9i"9    D0018525


Bulk Code (if applicable):    N/a

xxxx


CAD Cam Ref: 6-ert-D0018525-57.5x19.5x109.5mm Printer: Nampak Healthcare (Previously Storey Evans) Substrate:    Carton Board - White


Edgemark Position:    N/a

Pharmacode No/NE: 11000111(454)


Print and Technical Colours


VRN-HighGloss Water Based _Emul


Braille


Pharmacode Reads This Way


3oOC 9Aoqe 0jo;s iou oa N3aaTIH3 do H3V3H ONV1H9IS 3H130 IflO d33>l ■uojjBiujojuuaijijn} jo} j0|}B9| pasopua 00s ■0UjUB|B|Au0i}d }o aojnos b y(LS63) aiuBjJBdsB i\\m pauaiaa/ws si pnpojd SjqnBqi 9}ou 'Bunuo}9>||Au9qd 9Aeq noA}| pnpojd s\i\\ 6up|Bi ajojaq jopop jnoA}|nsuoo 9SB9|d sips asaqijo J0i}i|0 ui papuisaj p;p b mo||0} 0} pasjApB uaaq 9ABq noA}| -wmoiBO pus uimssBiod 'tumpos sumpoo aupipaiu s;qx jopop jnoAnnsuoo sAsp l Jaije Jsjsjad siuo;diuAs }| aojAps Ibojp0lu uo U0>|B} aq A|uo ppoqs :sjb9A zi japun uajpuqoawjipaq }B pus spaiu J0}}B sp'iqs} Z oi [ 9>|B} jnooo siuoidiuAs uaqyyy :j9ao pus sjbbA zi uajpnqo pus A|jap|a aqi Bujpnpu; i|np\/ 'Bu;mo||baas 9J0}aq A|q6nojoqiAAaqQ 'uojpjpmjiupB |bjo joj :0Bbsoq -BmpaajpBajq jo pBu6ajd 9jb noA}j p'npojd sjqi 9>|B} ubo no^ 'U9p|B jo JsBns uppoo pu op spiqsi aqi 'spajpajBu; 9a;pb aqi'ss apuoqjBOjq iun;ssBpd Blu 00L pus 0}buiB|b tumpos Buj 00S suppoo p|qs} apBAAaqo qosg ^sp|qs} asaqi 0JB pqyy\

9d|d poo}

aqi op; Brndsosa pios qoBiuop Bu;paA9jd os spapoo qaaiuop aqpo do} uo joAbi aAjpapjd b Bujiujo} Aq >|joaa qoiqM 'spsssajddns xnpaj, pa|po auppaiu }o adA} b bjb Aaq_[ 'AousuBajd Buurip pus spaiu jay's jnooo ubo a|diuBxa jo} qoiqM 'ujnqjjBaq pus uojpaBjpu; 'uojpijBjnBaj ppB }o jjo}ujoos!p pus upd aq; iuoj}}a;pj appoj'd spiqsi apBAAaqQ p;i/\| abuBApv uoosjABg


COLOURS TO MATCH RECOGNISED STANDARDS


BARCODE 11MEO


Barcode Type:    EAN 13

Barcode Number:    5000158067745

Magnification:    90°/o

BWR:    10 microns

Truncated by (smallest Bar): 7.6 mm Encoded Data:_N/A_


All other aspects of the bar code to conform to the current GS1 Operating Manual or other agreed commercial standard.


TBR787-D0018525

• •

• •

• •

• •

• •

• •

• •


TRIDENT

Connaught Bouse, Connaught Road, Kingswood Business Park, Hull, HU7 3AP, England. T: +44 (0) 1482 828100


Please note that any low resolution paper Canon colour copies associated with this job should be referred to for content, layout and colour separation only.


• •


STUDIO USE ONLY Lee Hardey    vi.o

Sm*Art check results: G=3; 0=0; R=0; - LH -14/10/10 13:44:17


GAVISCON ADVANCE MINT CHEWABLE TABLETS


ARTWORK APPROVAL


Approved by Sonoco Trident on behalf of Reckitt Benckiser

Signed:______________________

Date:_______________________


CUSTOMER INFO: Minimum Point Size = 6.3 pt

UNDER NO CIRCUMSTANCES SHOULD THIS ARTWORK BE ALTERED WITHOUT PRIOR PERMISSION FROM TRIDENT.

Tel. Alan Smith: +44 (0)1482 710304


NOT APPROVED FOR COLOUR


RBH Artwork


Pharmacode Reads This Way



gaviscon

ADVANCE MINT CHEW ABLE TABLETS

O CHEWABLE I £ TABLETS

ISCON

r ADVANCE

MINT CHi-WAbLE TABLETS
sodium alginate potassium bicarbonate

Heartburn and IndigestionLong Lasting


and Print Specification

Trident Reference No:

TR377640

=1

Action / Version:

C

Brand:

Gaviscon

=1

Brand Platform:

Adult

Sub Platform:

500mg Tablet

==

Sub Brand:

Peppermint

-=

Format:

Tablet

==

Delivery:

Blister

=1

Pack Size:

12s

Country:

UK

=1

Date Created:

25/05/10

-

Date Modified:

14/10/10

=1

RBH Contact:

Lori Glasgow

3

O ' 00

CN

O

CN

O - LD

CN

O

- LD

CN

Artwork Type: Commercial Print

Component Code (2D if applicable):    0284409


SPap^J,ioni:CalPaCka9i"9    D0018525


Bulk Code (if applicable):    N/a

xxxx


CAD Cam Ref: 6-ert-D0018525-57.5x19.5x109.5mm Printer: Nampak Healthcare (Previously Storey Evans) Substrate:    Carton Board - White


Edgemark Position:    N/a

Pharmacode No/NE: 11000111(454)




'3o0£ 3Aoqe 0jo;s iou oa N3dQTIH0 do H3V3U ONV1H9IS 3H1 do ino d33>l ■uojjBiujojuuaijijn} jo} j0|}B9| pasopua 00s ■0UjUB|B|Au0i}d }o aojnos b y(LS63) aiuBjJBdsB i\\m pauaiaa/ws si pnpojd SjqnBqi 9}ou 'Bunuo}9>||Au9qd 9Aeq noA}| pnpojd s\i\\ 6up|Bi ajojaq jopop jnoA}|nsuoo 9SB9|d sips asaqijo J0i}i|0 ui papuisaj p;p b mo||0} 0} pasjApB uaaq 9ABq noA}| -wmoiBO pus wmssBiod 'tumpos sumpoo aupipaiu s;qx jopop jnoA}|nsuoo sAsp l Jaije Jsjsjad siuo;diuAs }| aojAps Ibojp0lu uo U0>|B} aq A|uo ppoqs :sjb9A zi japun uajpuqoawjipaq }B pus spaiu J0}}B sp'iqs} Z oi [ 9>|B} jnooo siuoidiuAs uaqyyy :j9ao pus sjbbA zi uajpnqo pus A|jap|a aqi Bujpnpu; i|np\/ 'Bu;mo||baas 9J0}aq A|q6nojoqiMaqQ 'uojpjpmjiupB |bjo joj :0Bbsoq -BmpaajpBajq jo pBu6ajd 9jb noA}j p'npojd sjqi 9>|B} ubo no^ 'U9p|B jo JsBns uppoo pu op spiqsi aqi 'spajpajBu; 9a;pb aqi'ss apuoqjBOjq wmssBiod Blu 00L pus 0}buiB|b tumpos Buj 00S suppoo p|qs} apBAAaqo qosg ^sp|qs} asaqi 0JB pqyy\

9d|d poo}

aqi op; Bmdsosa pios qoBiuop Bu;paA9jd os spapoo qaaiuop aqpo do} uo joAbi aAjpapjd b Bujiujo} Aq >|joaa qoiqM 'spsssajddns xnpaj, pa|po auppaiu }o adA} b bjb Aaq_[ 'AousuBajd Buurip pus spaiu jay's jnooo ubo a|diuBxa jo} qoiqM 'ujnqjjBaq pus uojpaBjpu; 'uojpijBjnBaj ppB }o jjo}ujoos!P pus upd aq; iuoj}}a;pj appoj'd spiqsi apBMaqQ p;|/\| abuBApv uoosjABg



Print and Technical Colours




VRN-HighGloss Water Based _Emul


COLOURS TO MATCH RECOGNISED STANDARDS


BARCODE 11MEO


Barcode Type:    EAN 13

Barcode Number:    5000158067745

Magnification:    90°/o

BWR:    10 microns

Truncated by (smallest Bar): 7.6 mm Encoded Data:_N/A_


All other aspects of the bar code to conform to the current GS1 Operating Manual or other agreed commercial standard.


O

' OI CN


O -^

<N


O

- on

(N


O

- CN (N


O

CN


O

O

<N


O

- OO


O

-


o

- CD


o

- LD


o

- on


O

- CN


=1 O


o

-o


TBR787-D0018525


• • •

• •


• ••


•    •    ••    •    ••

•    •    •    •

•    •    •    •

•    ••    ••    •

•    •

•    •


TRIDENT

Connaught House, Connaught Road, Kingswood Business Park, Hull, HU7 3AP, England. T: +44 (0) 1482 828100


o


O

OO


o

CN


• ••


• • • • •


• • •


Please note that any low resolution paper Canon colour copies associated with this job should be referred to for content, layout and colour separation only.


o

" LD


• •


• •• • • •


GAVISCON ADVANCE MINT CHEWABLE TABLETS


STUDIO USE ONLY Lee Hardey    vi.o

Sm*Art check results: G=3; 0=0; R=0; - LH -14/10/10 13:44:17


ARTWORK APPROVAL


Approved by Sonoco Trident on behalf of Reckitt Benckiser

Signed:______________________

Date:_______________________


O

LD


O

on


o

" CN


CUSTOMER INFO: Minimum Point Size = 6.3 pt

UNDER NO CIRCUMSTANCES SHOULD THIS ARTWORK BE ALTERED WITHOUT PRIOR PERMISSION FROM TRIDENT.

Tel. Alan Smith: +44 (0)1482 710304


NOT APPROVED FOR COLOUR


E

E


Reckitt Benckiser


: T-3

GAVISCON


GAVISCON


r ADVANCE

MINTCHEWABLE

TABLETS


M


O A CHEWABLE TABLETS


GAVISCON


f ADVANCE

MINTCHEWABLE TABLETS

sodium alginate potassium bicarbonate

Heartburn and Indigestion • Long Lasting


C ADVANCE

MINTCHEWABLE

TABLETS



5 000158 067752 >


'3oOE 9Aoqe bjojs jou oq N3aailH3 dO H3V3H ONV1H3IS 3H1 dO 100 d33>l ■uonewjoju! J9i]yrqjo|i0|je9| pasopua bbs ■9ume|B|Au9Ljd jo aojnos b '(L56d) awBjJBdsB qijM pbubjbbms s; jonpojd siqueqj 0jou 'Bunuoj0>||Au0qcl babi| noA j| jonpojd S|qj 6up|Bi ajojaq joioop jnoA j|nsuoo 3SB3|d subs asaqjjo J0qjj0 u| paioujsaj j0jp b m0||0j. oj pasjAps U00q BABq noAj| uimo|BO pus mnjSSBjod 'uimpos sumiuoo amojpaui S|qj. vioioop jnoA unsuoo sAsp l jbijb isjsjad siuoiduiAs j| BOjApB |Bo;p0LU uo U9>|BJ aq A|uo p|noi|s :sjbbA zi Japun UBjpiiqg-aimjpaq ib pus s|bblu jays sjaiqBj Z oi i 9>|Bi jnooo sluoidujAs U9L|/y\ :jbao puB sjbbA zi uajpuqo pus A|j0p|0 Bq; Bmpnjou! i|npy ■BujAAOUBMS ajojaq A|qBnoioqi mbljq -uoqBJismjiupB |bjo jo-j ibBbsoq ■Bu!p99jiSB9jq jo lUBuBgjd bjb noA jj jonpojd sjqj 9>|Bi ubo nox u9in|B jo JBBns umiuoo iou op sisiqs; aqi siusjpBjBu; baijob aqj sb BiBuoqjBOiq uimssBiod Blu 00L pus sibu;B|B iun;pos Biu 00Q sumiuoo i9|qBi 9|qBM9qo qos^ ^si9|qBi 9S9qi bjb jbl|m

adjd pooj

9qi OIU! BUjdBDSB p|OB qOBUJOlS BupUBABJd OS SJU3JU00 qOBLUOlS 9qil0 dOl UO J3AB| 9A|10910jd

b BmiuJoj Aq >|jom qojqM 'sjUBSsajddns xnqaj, pa||BO amojpauj jo adA} b bjb Aaqj. -AouBuBajd Buunp pus s|B3iu j91J.B Jnooo ubo 3|duiBxa JOI LjOjqM 'ujiiqViBaq pus uopsaBipm 'uoqBijBjnBaj P;ob jo yojuioosip pus umd aqj uiojj ^a;|3J apjAOJd sjaiqBj. aiqB/waqg im|/\| abuBApy ubosjAsg


PL 00063/0613.


TBR791-D0064707

PVV1

H

B

H

H

fm

UM

Bl


GAVISCON ADVANCE MINT CHEWABLE TABLETS


CUSTOMER INFO: Minimum Point Size = 6.3 pt



RBH Artwork and Print Specification

3-

Trident Reference No:

TR379031

=

Action / Version:

C

Brand:

Gaviscon

=1

Brand Platform:

Adult

Sub Platform:

500mg Tablet

==

Sub Brand:

Peppermint

-=

Format:

Tablet

==

Delivery:

Blister

=1

Pack Size:

24s

=!—

Country:

UK

=!

Date Created:

01/06/10

-

Date Modified:

14/10/10

O

“ cn

CN

O 00

CN

O

“ IN

O

-    LD

(N

O

-    LD

CN

Lori Glasgow


Artwork Type: Commercial Print

Component Code (2D if applicable):    0284410

Parent Technical Packaging

Specification:


Na


CAD Cam Ref: G-crt-D0064707-57.5 x 39 x 109.5mm Printer: Nampak Healthcare (Previously Storey Evans) Substrate:    Carton Board - White


Edgemark Position:    NA

Pharmacode No/NE: 11000110(453)


Print and Technical Colours


COLOURS TO MATCH RECOGNISED STANDARDS


BARCODE INFO


Barcode Type:    EAN 13

Barcode Number:    5000158067752

Magnification:    90%

BWR:    10 microns

Truncated by (smallest Bar): 4.1 mm Encoded Data:_N/A_


All other aspects of the bar code to conform to the current GS1 Operating Manual or other agreed commercial standard.


G2S

TRIDENT


Connaught House, Connaught Road, Kingswood Business Park, Hull, HU7 3AP, England. T: +44 (0) 1482 828100


Please note that any low resolution paper Canon colour copies associated with this job should be referred to for content, layout and colour separation only.


STUDIO USE ONLY Lee Hardey    vi.o

Sm*Art check results: G=3; 0=0; R=0; - LH -14/10/1015:00:37


ARTWORK APPROVAL


Approved by Sonoco Trident on behalf of Reckitt Benckiser

Signed:______________________

Date:_______________________


DIVIDER MO C1RC01VISTAMCES SHOOED THIS ARTWORK BE ALTERED WITHOUT PRIOR PERMISSION PROM TRIDENT.

Tel. Alan Smith: +44 (0)1482 710304


O - ^

CN


O

- m

CN


o

- CN


O

-O

CN


O

- CTi


O - 00


o

- LD


O - N-


O

- CN


O

-o


_o

<n


O

" in


o

LD


_o


o

<n


Reckitt Benckiser

: ▼ .3

PL 00063/0613.


'3oOE 9Aoqe bjojs jou oq N3aailH3 dO H3V3H ONV1H3IS 3H1 dO IHO d33>l

■UOpBlUJOJU! J3qjjnjJ0Ji3|JB3| p9S0|9U9 BBS

■9umB|B|Au9Ljd jo sojnos e '(L56d) awBjJBdsB qijM pbubjbbms s; jonpojd siqueqj 0jou 'Bunuoja^iAuaqd babi| noA j| jonpojd S|qj 6up|Bi ajojaq joioop jnoA j|nsuoo 3SB3|d subs asaqjjo J0qjj0 u| paioujsaj j0jp b m0||0j. oj pasjAps U00q BABq noA j| uimoiBO pus mnjSSBjod 'uimpos sumiuoo amojpaui S|qj. vioioop jnoA unsuoo sAsp l jays isjsjad siuoiduiAs j| BOjApB |Bo;p0LU uo U9>|BJ aq A|uo p|Hoqs :sjbbA zi Japun UBjpiiqg-aimjpaq ib pus s|bblu jays sjaiqBj Z oi i 9>|Bi jnooo sluoidujAs U9L|/y\ :jbao puB sjbbA zi uajpuqo pus A|jap|3 Bq; Bmpniom i|npy ■6mAA0||BMS ajojaq A|qBnojoqiM3ij5 -uoqBJismjiupB |bjo jo-j ibBbsoq ■Bu!p99jiSB9jq jo lUBuBgjd bjb noA jj jonpojd sjqj 9>|Bi ubo nox u9in|B jo jsBns umiuoo iou op sisiqs; aqi siusjpBjBu; baijob aqj sb BiBuoqjBOiq uimssBiod Blu OOL Pub aieu;B|B iun;pos Biu OOQ sumiuoo ia|qei 9|qBM9qo qoB^ ^si9|qei 9S9qi bjb jbl|m

adjd pooj

9qi 01U! BUjdBDSB p|OB qOBUJOlS BupUBABJd OS SJU3JU00 qOBLUOlS 9qil0 dOl UO J3AB| 9A|10910jd

b Bmuijoj Aq >|jom qojqM 'sjUBSsajddns xnqaj, pa||BO amajpaw jo adA} b bjb Aaqj. -AouBuBajd Buurip pus s|B3iu jbjjb jnooo ubo 3|duiBxa joi LjOjqM 'ujiiqViBaq pus uopsaBipm 'uoqBijBjnBaj P;ob jo yojuioosip pus umd aqj uiojj ^a;|3J apjAOJd sjaiqBi B|qB/waq3 im|/\| boubapv ubosjABg

TBR791-D0064707

PVV1

H

B

H

H

fm

UM

Bl


GAVISCON ADVANCE MINT CHEWABLE TABLETS


CUSTOMER INFO: Minimum Point Size = 6.3 pt



RBH Artwork and Print Specification

3-

Trident Reference No:

TR379031

=

Action / Version:

C

Brand:

Gaviscon

=1

Brand Platform:

Adult

Sub Platform:

500mg Tablet

==

Sub Brand:

Peppermint

-=

Format:

Tablet

==

Delivery:

Blister

=1

Pack Size:

24s

=!—

Country:

UK

=!

Date Created:

01/06/10

-

Date Modified:

14/10/10

O

“ cn

CN

O 00

CN

O

“ IN

O

-    LD

(N

O

-    LD

CN

Lori Glasgow


Artwork Type: Commercial Print

Component Code (2D if applicable):    0284410

Parent Technical Packaging

Specification:


Na


CAD Cam Ref: G-crt-D0064707-57.5 x 39 x 109.5mm Printer: Nampak Healthcare (Previously Storey Evans) Substrate:    Carton Board - White


Edgemark Position:    NA

Pharmacode No/NE: 11000110(453)


Print and Technical Colours


COLOURS TO MATCH RECOGNISED STANDARDS


BARCODE INFO


Barcode Type:    EAN 13

Barcode Number:    5000158067752

Magnification:    90%

BWR:    10 microns

Truncated by (smallest Bar): 4.1 mm Encoded Data:_N/A_


All other aspects of the bar code to conform to the current GS1 Operating Manual or other agreed commercial standard.


G2S

TRIDENT


Connaught House, Connaught Road, Kingswood Business Park, Hull, HU7 3AP, England. T: +44 (0) 1482 828100


Please note that any low resolution paper Canon colour copies associated with this job should be referred to for content, layout and colour separation only.


STUDIO USE ONLY Lee Hardey    vi.o

Sm»Art check results: G=3; 0=0; R=0; - LH -14/10/1015:00:37


ARTWORK APPROVAL


Approved by Sonoco Trident on behalf of Reckitt Benckiser

Signed:______________________

Date:_______________________


DIVIDER MO C1RC01VISTAMCES SHOOED THIS ARTWORK BE ALTERED WITHOUT PRIOR PERMISSION PROM TRIDENT.

Tel. Alan Smith: +44 (0)1482 710304


O - ^

CN


O

- m

CN


o

- CN


O

-O

CN


O

- CTi


O - 00


o

- LD


O - N-


O

- CN


O

-o


_o

<n


O

" in


o

LD


_o


o

<n


Pharmacode Reads This Way

->


First Bar    Last Bar


:----------i-------------1---1    1---i----------

PATIENT INFORMATION LEAFLET ! GAVISCCjIN ADVANCE MINT CHEWABLE TABLETS |    i    Sodium lalginate    i

i    | Potassium bicarbonate |

[Please read this leaflet carefully before you take this medicine. If you are not sufe about anything d$k your pharmacist or doctor.

fVhat are Gaviscon Advance Mint Chewable Tablets?

Gaviscon Advance Mint Chewable [Tablets belong to a group of medicines called ‘reflux suppressants’, which form a protective layer bn top of the stomach contents to prevent stomach acid' escaping from [the stomach where it works into the food pipe causing pain and discomfort.


Mhat are Gaviscon Advance Mint Chewable Tablets used for?

Gaviscon Advance Mint Chewable [Tablets are used for! the treatment of symptoms ofj gastro-oesophageaj reflux such as acid[ regurgitation, heartburn and indigestion, which may occur, for example, following fneals or during pregnancy, and in patients with symptoms related to oesophagitis. [    [    [

it can also he used to relieve the symptoms of conditions such as hiatus hernia (protrusion of muscle'through a muscle wall), symptoms of hoarseness and other voice disorders, sore throat and cough associated with [reflux. It can he ta^en to control heartbjum symptoms Which may occur while taking, or following withdrawal of medication to reduce stomalch acid such as Proton Pump Inhibitors! (PPI’s) or H2 Antagonists.    [    [    [


Before using daviscon Advance Mint Chewable Tablets:

'Do not take this product if:    [    [

i* You know yoji are allergic to any) of the ingredients ^s very rarely [ difficulty in breathing and skin rashes have occurred'(see further ' information for a full list of ingredients).    !


[Take special c^re before treatment with Gaviscon Advance Mint phewable Tablets:

This medicine contains sodium (4.5 mmol per two-tablet dose), potassium (2.0 (nmol per two-tablef dose) and calcium [(2.0 mmol per )wo-tahlet dose}.

[• If you have been advised to follow a diet restricted in any of these i salts please consult your doctor tjefore taking this product.

[• Please also talk to your doctor regarding these salt contents if you [ suffer or have suffered from significant kidney or heart disease, as ' certain salts cjould interfere with these diseases. [

[If you have phenylketonuria, note that this product is sweetened with aspartame, a source of phenylalanine.    [


These tablets do[hot contain sugar of gluten.

Gaviscon Advance Mint Chewable tablets are available in pack sizes of [ !l2’s & 24’s.    [

Manufacturer atid PL Holder:

keckitt BenckisCr Healthcare (UK) Limited, Dansom Lahe, Hull,

[HU8 7DS.

fclaviscon and (J) are trade marks.

Text revised: Mgy 2014


1.3.2 Mock-up

Gaviscon Advance Chewable National Tablets 0019964


'Taking other njedicines    ~[    [

please tell your doctor or pharmacist if you are taking or'have recently taken any other medicines, including medicines obtained without [prescription. [    [    [

[Pregnancy and[ breast-feeding: [

[You can take thils product if you are pregnant or breast- feeding. As with 'all medicines, tt)e treatment duration! should be limited aji much as possible.


flow to take Gaviscon Advance Mint Chewable Tablets:

'For oral administration. Chew thoroughly before swallowing.

[Adults and children over 12 years! When symptoms occur take one to [two tablets after meals and at bedtime.    i

[Children under 12 years: Should only be taken on medical advice.

[If you forget a dose it is not necessary to double the dose next time, just [carry on taking (is before.    [    [

[If you take too much of this product you may feel bloated. It is unlikely [to cause you any harm, but please consult your doctor or[ pharmacist.

[After taking Gaviscon Advance Mint Chewable Tablets:

[If symptoms persist after 7 days consult your doctor.    i


Possible side effects    [    [

[Very rarely (less than 1 in 10,000 patients treated), there is chance of an [allergic reaction! to the ingredients. Symptoms of this maiy include skin rash, difficulty ih breathing, dizziness, or swelling of the[face, lips, tongue or throat[ If you experience these or any other side-effects stop faking the product and consult your doctor or pharmacist.

if you get any side effects, talk to yo[ur doctor, pharmacist or nurse. This fncludes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: i"http://www.mhfa.gov.uk/yellowcar<jl". By reporting sid^ effects, you [can help provide more information on the safety of this medicine.


'Storing your medicine:    [    [    [

t)o not use after[ the expiry date (EXf* month/year) showfi on the pack. ' [KEEP OUT OF THE REACH AND SIGHT OF CHILDREN.

[Do not store above 30°C. Store in th]e original package. [    [

[Further information

[Gaviscon Advance Mint Chewable ’tablets are off-white to cream,    i

'circular, flat with bevelled edges tablets with the odour a[nd flavour of [ peppermint. Eacjh tablet contains sodium alginate 500 mg and potassium [ bicarbonate 100'mg as the active ingredients.    '    '

The other ingredients are mannitol (E421), calcium carbonate, macrogol! 20,000, magnesium stearate, aspartajne (E951), mint flavour, acesulfam^ potassium, copovidone.    '    '    '


_[___RB49358


RB49358


Page 8